Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Incidence and distribution of extravascular compression of extracranial venous pathway in patients with chronic cerebrospinal venous insufficiency and multiple sclerosis.
A passive exoskeleton can push your life up: application on multiple sclerosis patients.
Relationship of UV exposure to prevalence of multiple sclerosis in England.
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
Therapeutic strategies of urinary disorders in MS. Practice and algorithms.
Lingo-1 Inhibited by RNA Interference Promotes Functional Recovery of Experimental Autoimmune Encephalomyelitis.
Association Between Physical Fitness and Cognitive Function in Multiple Sclerosis: Does Disability Status Matter?
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.
Building an RNA Sequencing Transcriptome of the Central Nervous System.
Experience with Fingolimod in Clinical Practice.
Human glial chimeric mice reveal astrocytic dependence of JC virus infection.
Pilot study of minocycline in relapsing-remitting multiple sclerosis.
A microbial symbiosis factor prevents intestinal inflammatory disease.
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis.
An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
Hand dexterity and direct disease related cost in multiple sclerosis.
Combinatorial actions of Tgfβ and Activin ligands promote oligodendrocyte development and CNS myelination.
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.
Vitamin d and multiple sclerosis.
The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model.
Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria.
LSN MS guidelines for the management of multiple sclerosis.
Explaining temporal trends in annualised relapse rates in placebo groups of randomised controlled trials in relapsing multiple sclerosis: systematic review and meta-regression.
[Compensatory mechanisms in multiple sclerosis(review)].

Pages